# Stoke Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/stoke-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 24 | | Claims under review | 1 | | Evidence records | 5 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-17T04:46:03.28502+00:00 | | Last reviewed | 2026-10-17T04:46:03.28502+00:00 | ## Identity - Legal name: Stoke Therapeutics, Inc. - Display name: Stoke Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T20:47:31.05797+00:00 | | Completeness | 0.364 | | Record Quality | 0.829 | | Directors | 13 | | Committees | 0 | | Governance events | 8 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | NOT_REVIEWED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Arthur A. Levin: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2015-01-01. claim_id=alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:7 - Arthur O. Tzianabos: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2024-01-01. claim_id=alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:8 - Edward M. Kaye: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2017-01-01. claim_id=alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:9 - G. Clare Kahn: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-01-01. claim_id=alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:11 - Jennifer C. Burstein: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2019-01-01. claim_id=alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:14 - Stoke Therapeutics: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2014-01-01. claim_id=alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:17 - Adrian R. Krainer, Ph.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:6 - Arthur O. Tzianabos, Ph.D.: Chairman of the Board. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:5 - Edward M. Kaye, M.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:10 - G. Clare Kahn, Ph.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:12 - Ian F. Smith: Chief Executive Officer and Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:13 - Julie Anne Smith: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:15 - Seth L. Harrison, M.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:16 ## Executive leadership - Barry S. Ticho: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:18 - Jonathan Allan: General Counsel and Corporate Secretary [GC]. Status: current. claim_id=alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:22 - Barry S. Ticho, M.D., Ph.D., FACC: Chief Medical Officer. Status: unknown. claim_id=alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:19 - Ian F. Smith: Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:20 - Jason Hoitt: Chief Patient Officer. Status: unknown. claim_id=alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:21 - Jonathan Allan, J.D.: General Counsel and Corporate Secretary [GC]. Status: unknown. claim_id=alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:23 - Thomas E. Leggett: Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:24 ## Governance events - EXECUTIVE_APPOINTED: Barry S. Ticho executive of Stoke Therapeutics, Inc., effective 2026-04-22. Effective: 2026-04-22. Detected: 2026-10-17T04:46:03.28502+00:00. event_id=alpha:event:transition:1g8vlvqbu8yuy - GC_CHANGED: Jonathan Allan executive of Stoke Therapeutics, Inc., effective 2026-04-22. Effective: 2026-04-22. Detected: 2026-10-17T04:46:03.28502+00:00. event_id=alpha:event:transition:1uhf7d71yowvh3 - DIRECTOR_APPOINTED: G. Clare Kahn seat on Stoke Therapeutics, Inc., effective 2026-01-01. Effective: 2026-01-01. Detected: 2026-10-17T04:46:03.28502+00:00. event_id=alpha:event:transition:3qhrho3skdew - DIRECTOR_APPOINTED: Arthur O. Tzianabos seat on Stoke Therapeutics, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-17T04:46:03.28502+00:00. event_id=alpha:event:transition:d8bx88ygk8ny - DIRECTOR_APPOINTED: Jennifer C. Burstein seat on Stoke Therapeutics, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-17T04:46:03.28502+00:00. event_id=alpha:event:transition:wqv8xk7o7l5 - DIRECTOR_APPOINTED: Edward M. Kaye seat on Stoke Therapeutics, Inc., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-17T04:46:03.28502+00:00. event_id=alpha:event:transition:1s046yp9f3y9r - DIRECTOR_APPOINTED: Arthur A. Levin seat on Stoke Therapeutics, Inc., effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-17T04:46:03.28502+00:00. event_id=alpha:event:transition:1j2xoo3142u0cn - DIRECTOR_APPOINTED: Stoke Therapeutics seat on Stoke Therapeutics, Inc., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-17T04:46:03.28502+00:00. event_id=alpha:event:transition:14f29prgyd09j ## Scoped resources - `alpha://company/stoke-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/stoke-therapeutics-inc?format=record - `alpha://company/stoke-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/stoke-therapeutics-inc?format=record§ion=identity - `alpha://company/stoke-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/stoke-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/stoke-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/stoke-therapeutics-inc?format=record§ion=board - `alpha://company/stoke-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/stoke-therapeutics-inc?format=record§ion=committees - `alpha://company/stoke-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/stoke-therapeutics-inc?format=record§ion=leadership - `alpha://company/stoke-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/stoke-therapeutics-inc?format=record§ion=ownership - `alpha://company/stoke-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/stoke-therapeutics-inc?format=record§ion=financials - `alpha://company/stoke-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/stoke-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/stoke-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/stoke-therapeutics-inc?format=record§ion=compensation - `alpha://company/stoke-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/stoke-therapeutics-inc?format=record§ion=governance - `alpha://company/stoke-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/stoke-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/stoke-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/stoke-therapeutics-inc?format=record§ion=audit - `alpha://company/stoke-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/stoke-therapeutics-inc?format=record§ion=legal - `alpha://company/stoke-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/stoke-therapeutics-inc?format=record§ion=risk - `alpha://company/stoke-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/stoke-therapeutics-inc?format=record§ion=cyber - `alpha://company/stoke-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/stoke-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/stoke-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/stoke-therapeutics-inc?format=record§ion=agents - `alpha://company/stoke-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/stoke-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/stoke-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/stoke-therapeutics-inc?format=record§ion=events - `alpha://company/stoke-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/stoke-therapeutics-inc?format=record§ion=relationships - `alpha://company/stoke-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/stoke-therapeutics-inc?format=record§ion=assessments - `alpha://company/stoke-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/stoke-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - NO_RECORDS_FOUND ## Leadership - Arthur O. Tzianabos, Ph.D.: Chairman of the Board. Claim: alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:dabd2f1bab9124362d8932a2af718aa6a433b765e143e556211fec027d108eff. - Adrian R. Krainer, Ph.D.: Director. Claim: alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:dabd2f1bab9124362d8932a2af718aa6a433b765e143e556211fec027d108eff. - Arthur A. Levin: Director. Claim: alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:7. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7faf31b178d6159b65198897004dd746903e39bf71849ecad5833a891bf89087. - Arthur O. Tzianabos: Director. Claim: alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:8. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7faf31b178d6159b65198897004dd746903e39bf71849ecad5833a891bf89087. - Edward M. Kaye: Director. Claim: alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:9. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7faf31b178d6159b65198897004dd746903e39bf71849ecad5833a891bf89087. - Edward M. Kaye, M.D.: Director. Claim: alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:dabd2f1bab9124362d8932a2af718aa6a433b765e143e556211fec027d108eff. - G. Clare Kahn: Director. Claim: alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:11. Valid from: 2026-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7faf31b178d6159b65198897004dd746903e39bf71849ecad5833a891bf89087. - G. Clare Kahn, Ph.D.: Director. Claim: alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:dabd2f1bab9124362d8932a2af718aa6a433b765e143e556211fec027d108eff. - Ian F. Smith: Chief Executive Officer and Director. Claim: alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:dabd2f1bab9124362d8932a2af718aa6a433b765e143e556211fec027d108eff. - Jennifer C. Burstein: Director. Claim: alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:14. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7faf31b178d6159b65198897004dd746903e39bf71849ecad5833a891bf89087. - Julie Anne Smith: Director. Claim: alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:dabd2f1bab9124362d8932a2af718aa6a433b765e143e556211fec027d108eff. - Seth L. Harrison, M.D.: Director. Claim: alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:dabd2f1bab9124362d8932a2af718aa6a433b765e143e556211fec027d108eff. - Stoke Therapeutics: Director. Claim: alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:17. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7faf31b178d6159b65198897004dd746903e39bf71849ecad5833a891bf89087. - Barry S. Ticho: Chief Medical Officer. Claim: alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:18. Valid from: 2026-04-22. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c71eabe8070dbe7634993d0c2741793fcdbecb8bba0842854394d243f58994b7. - Barry S. Ticho, M.D., Ph.D., FACC: Chief Medical Officer. Claim: alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:dabd2f1bab9124362d8932a2af718aa6a433b765e143e556211fec027d108eff. - Ian F. Smith: Chief Executive Officer. Claim: alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:dabd2f1bab9124362d8932a2af718aa6a433b765e143e556211fec027d108eff. - Jason Hoitt: Chief Patient Officer. Claim: alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:dabd2f1bab9124362d8932a2af718aa6a433b765e143e556211fec027d108eff. - Jonathan Allan: General Counsel and Corporate Secretary. Claim: alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:22. Valid from: 2026-04-22. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8241066228adede4c60b7169bb294af6a46507fb4906eeecf63bf2917aa7c081. - Jonathan Allan, J.D.: General Counsel and Corporate Secretary. Claim: alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:dabd2f1bab9124362d8932a2af718aa6a433b765e143e556211fec027d108eff. - Thomas E. Leggett: Chief Financial Officer. Claim: alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:leadership_role:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:dabd2f1bab9124362d8932a2af718aa6a433b765e143e556211fec027d108eff. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Stoke Therapeutics, Inc.. Claim: alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:bcf4fe6a68ba53f9086e4590ac76dfd4502745d8260efee5d51babd1610b6718. ## Entity Status - Public listing published. Claim: alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:bcf4fe6a68ba53f9086e4590ac76dfd4502745d8260efee5d51babd1610b6718. ## Published Fact - US. Claim: alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:bcf4fe6a68ba53f9086e4590ac76dfd4502745d8260efee5d51babd1610b6718. ## Security Listing - STOK (NASDAQ). Claim: alpha:claim:company:bbe1f85f-8f37-4051-a3de-418dac6ca3ee:security_listing:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:bcf4fe6a68ba53f9086e4590ac76dfd4502745d8260efee5d51babd1610b6718. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:bcf4fe6a68ba53f9086e4590ac76dfd4502745d8260efee5d51babd1610b6718: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/stoke-therapeutics-inc). - alpha:projection-evidence:document:dabd2f1bab9124362d8932a2af718aa6a433b765e143e556211fec027d108eff: [SEC DEF 14A 0001193125-26-170362](https://www.sec.gov/Archives/edgar/data/1623526/000119312526170362/d941184ddef14a.htm). - alpha:projection-evidence:document:7faf31b178d6159b65198897004dd746903e39bf71849ecad5833a891bf89087: [DEF 14A d941184ddef14a.htm](https://www.sec.gov/Archives/edgar/data/1623526/000119312526170362/d941184ddef14a.htm). - alpha:projection-evidence:document:c71eabe8070dbe7634993d0c2741793fcdbecb8bba0842854394d243f58994b7: [STOK DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1623526/000119312526170362/d941184ddef14a.htm). - alpha:projection-evidence:document:8241066228adede4c60b7169bb294af6a46507fb4906eeecf63bf2917aa7c081: [STOK DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1623526/000119312526170362/d941184ddef14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/stoke-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/stoke-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/stoke-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/stoke-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/stoke-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T20:47:30.860121+00:00; recorded 2026-10-17T20:47:30.860121+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.